Cargando…

Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies

Detalles Bibliográficos
Autor principal:	Condò, Ivano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9223693/ https://www.ncbi.nlm.nih.gov/pubmed/35742964 http://dx.doi.org/10.3390/ijms23126525

Ejemplares similares

Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing
por: Jia, Fangzhi, et al.
Publicado: (2022)

The expanding spectrum of rare monogenic autoinflammatory diseases
por: Touitou, Isabelle, et al.
Publicado: (2013)

Special Issue: Metabolic Bone Diseases: Molecular Biology, Pathophysiology and Therapy
por: Xourafa, Anastasia, et al.
Publicado: (2023)

Understanding inborn errors of immunity: A lens into the pathophysiology of monogenic inflammatory bowel disease
por: Ouahed, Jodie Deborah
Publicado: (2022)

Gene Therapy: Novel Approaches to Targeting Monogenic Epilepsies
por: Goodspeed, Kimberly, et al.
Publicado: (2022)

When Development of the Alveolar Gas Exchange Unit Fails: Universal Single-Cell Lessons from Rare Monogenic Disorders
por: Schupp, Jonas C., et al.
Publicado: (2023)

Clinical and Molecular Perspectives of Monogenic Hypertension
por: Levanovich, Peter E., et al.
Publicado: (2020)

Hepatotoxicity: Molecular Mechanisms and Pathophysiology
por: Teschke, Rolf
Publicado: (2019)

The frequency of rare and monogenic diseases in pediatric organ transplant recipients in Italy
por: Vaisitti, Tiziana, et al.
Publicado: (2021)

VEXAS syndrome: an adult-onset monogenic autoinflammatory disease with many unanswered questions
por: Hernández-Rodríguez, José, et al.
Publicado: (2023)

The prospect of molecular therapy for Angelman syndrome and other monogenic neurologic disorders
por: Bailus, Barbara J, et al.
Publicado: (2014)

Novel Molecular Approaches to the Understanding of Pathophysiologal Mechanisms Acting in Human Embryos: An Editorial
por: Kovacs, Gabor L., et al.
Publicado: (2022)

Molecular Mechanisms of Peritoneal Membrane Pathophysiology
por: Zarogiannis, Sotirios G., et al.
Publicado: (2022)

Rethinking monogenic neurological diseases
por: Chen, Wan-Jin, et al.
Publicado: (2020)

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

What Can RNA-Based Therapy Do for Monogenic Diseases?
por: Clarke, Luka A., et al.
Publicado: (2023)

Monogenic Epilepsies: Disease Mechanisms, Clinical Phenotypes, and Targeted Therapies
por: Guerrini, Renzo, et al.
Publicado: (2021)

Molecular Mechanisms and Pathophysiology of Ischemia-Reperfusion Injury
por: Panisello-Roselló, Arnau, et al.
Publicado: (2018)

Monogenic hypertension
por: Precone, Vincenza, et al.
Publicado: (2019)

Monogenic hyperlipidemias
por: Krasi, Geraldo, et al.
Publicado: (2019)

Application of full-genome analysis to diagnose rare monogenic disorders
por: Shieh, Joseph T., et al.
Publicado: (2021)

Pathophysiology, clinical manifestations and current management of IL-1 mediated monogenic systemic autoinflammatory diseases, a literature review
por: Li, Yandie, et al.
Publicado: (2022)

Prostate Cancer: Pathophysiology, Pathology and Therapy
por: Tzelepi, Vasiliki
Publicado: (2022)

Overactive Bladder: Pathophysiology, Diagnostics, and Therapies
por: Heesakkers, John P. F. A., et al.
Publicado: (2011)

Ovarian Cancer: Advances in Pathophysiology and Therapies
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Autophagy in Development, Cell Differentiation, and Homeodynamics: From Molecular Mechanisms to Diseases and Pathophysiology
por: Nezis, Ioannis P., et al.
Publicado: (2014)

Gene Therapies for Monogenic Autism Spectrum Disorders
por: Weuring, Wout, et al.
Publicado: (2021)

Molecular Diagnosis and Novel Therapies for Neuromuscular Diseases
por: Maruyama, Rika, et al.
Publicado: (2020)

The Revolution in Human Monogenic Disease Mapping
por: Duncan, Emma, et al.
Publicado: (2014)

DNA Methylation in the Diagnosis of Monogenic Diseases
por: Cerrato, Flavia, et al.
Publicado: (2020)

Prenatal genetic diagnosis of monogenic diseases
por: Prior-de Castro, Carmen, et al.
Publicado: (2023)

Osteoarthritis and Cartilage Regeneration: Focus on Pathophysiology and Molecular Mechanisms
por: Grässel, Susanne, et al.
Publicado: (2019)

Translational potential of base-editing tools for gene therapy of monogenic diseases
por: Reshetnikov, Vasiliy V., et al.
Publicado: (2022)

A Look to Future Directions in Gene Therapy Research for Monogenic Diseases
por: Porteus, Matthew H, et al.
Publicado: (2006)

Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
por: Pelagatti, Maria A, et al.
Publicado: (2014)

Impact of gene therapy for canine monogenic diseases on the progress of preclinical studies
por: Switonski, Marek
Publicado: (2020)

Pathophysiological lessons from rare associations of immunological disorders
por: Ronco, Pierre, et al.
Publicado: (2009)

Biochemistry of Autoinflammatory Diseases: Catalyzing Monogenic Disease
por: Beck, David B., et al.
Publicado: (2019)

Strategies to Advance Drug Discovery in Rare Monogenic Intellectual Disability Syndromes
por: Hettige, Nuwan C, et al.
Publicado: (2017)

SHANK3 haploinsufficiency: a “common” but underdiagnosed highly penetrant monogenic cause of autism spectrum disorders
por: Betancur, Catalina, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_72p2h71gpc36898mu5amf056b3